A pharmaceutical composition for the treatment of obesity or...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/00 (2006.01) A61K 45/06 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2534271

Pharmaceutical compositions are disclosed for the treatment of obesity, an overweight condition and compulsive overeating. The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotinic receptor partial agonist and an alpha2dela ligand and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.

Compositions pharmaceutiques destinées au traitement de l'obésité, de la surcharge pondérale et de la frénésie alimentaire. Ces compositions pharmaceutiques sont constituées par une association efficace sur le plan thérapeutique d'un agoniste partiel des récepteurs nicotiniques et d'un ligand alpha2delta, ainsi que par un excipient pharmaceutiquement acceptable. On a également prévu un procédé de mise en oeuvre de composé de ce type.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A pharmaceutical composition for the treatment of obesity or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A pharmaceutical composition for the treatment of obesity or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A pharmaceutical composition for the treatment of obesity or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1633803

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.